HUM
Humana Inc.
Price Chart
Latest Quote
$361.64
+2.51 (+0.70%)
Current Price
| Previous Close | $359.13 |
| Open | $361.93 |
| Day High | $365.62 |
| Day Low | $353.06 |
| Volume | 1,016,970 |
Stock Information
| Quarterly Dividend / Yield | $3.54 / 0.99% |
| Shares Outstanding | 120.06M |
| Quarterly Dividend Yield | 0.99% |
| Quarterly Dividend | $3.54 |
| Total Debt | $14.37B |
| Cash Equivalents | $21.97B |
| Revenue | $137.20B |
| Net Income | $1.13B |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $43.42B |
| P/E Ratio | 38.60 |
| EPS (TTM) | $9.37 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $35.89B |
| Sales | $137.20B |
| Income | $1.13B |
| Book/sh | $154.75 |
| Cash/sh | $182.95 |
| Employees | 67K |
Financial Ratios
| Quick Ratio | 1.26 |
| Current Ratio | 1.77 |
| Debt/Eq | 77.07 |
| EPS Growth TTM | -4.70% |
Returns & Margins
| ROA | 3.64% |
| ROE | 6.28% |
| Gross Margin | 14.01% |
| Operating Margin | 4.67% |
| Profit Margin | 0.82% |
Ownership
| Insider Ownership | 0.21% |
| Institutional Ownership | 99.90% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 22.99 |
| PEG | 2.04 |
| P/S | 0.32 |
| P/B | 2.34 |
Analyst Data
| Recommendation | hold |
| Target Price | $301.62 |
Technical Indicators
| SMA20 | $349.12 |
| SMA50 | $291.71 |
| SMA200 | $248.43 |
| RSI | 72.29 |
| ATR | 12.3354 |
| Shares Float | 119.80M |
| Short Float | 5.79% |
| Short Ratio | 3.50 |
| Volatility | 0.77 |
| Rel Volume | 0.70 |
Performance History
| Week | -2.12% |
| Month | +17.43% |
| Quarter | +111.04% |
| 6 Months | +40.60% |
| YTD | +37.43% |
| Year | +56.55% |
| 3 Years | -15.88% |
| 5 Years | -11.27% |
| 10 Years | +122.28% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $361.64 | 1,016,970 |
| 2026-06-23 | $359.13 | 1,568,500 |
| 2026-06-22 | $360.72 | 1,705,900 |
| 2026-06-18 | $360.65 | 3,571,100 |
| 2026-06-17 | $362.00 | 1,420,200 |
| 2026-06-16 | $369.49 | 1,697,100 |
| 2026-06-15 | $380.26 | 1,784,600 |
| 2026-06-12 | $379.22 | 980,000 |
| 2026-06-11 | $368.69 | 1,097,700 |
| 2026-06-10 | $364.46 | 960,800 |
| 2026-06-09 | $363.18 | 1,436,000 |
| 2026-06-08 | $355.98 | 1,117,700 |
| 2026-06-05 | $350.08 | 1,739,400 |
| 2026-06-04 | $349.80 | 1,892,200 |
| 2026-06-03 | $327.54 | 1,125,100 |
| 2026-06-02 | $320.88 | 919,700 |
| 2026-06-01 | $328.31 | 1,954,600 |
| 2026-05-29 | $305.42 | 1,575,200 |
| 2026-05-28 | $308.70 | 576,600 |
| 2026-05-27 | $306.27 | 724,900 |
| 2026-05-26 | $301.69 | 698,100 |
About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
đ° Latest News
Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027
Simply Wall St. âĸ 2026-06-25T02:08:31Z
Can Humana's Margin Recovery Drive Long-Term Earnings Growth?
Zacks âĸ 2026-06-24T15:25:00Z
Hereâs What Hit Humana (HUM) in Q1
Insider Monkey âĸ 2026-06-23T13:10:01Z
CVS Health (CVS) Under the Microscope After Recent Healthcare Report
Insider Monkey âĸ 2026-06-23T08:35:48Z
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?
Zacks âĸ 2026-06-22T16:51:00Z
1 S&P 500 Stock on Our Buy List and 2 We Ignore
StockStory âĸ 2026-06-19T15:16:58Z
2 High-Flying Stocks to Target This Week and 1 Facing Challenges
StockStory âĸ 2026-06-18T15:57:28Z
3 Stocks Doing the Heavy Lifting in Healthcareâs Rebound
MarketBeat âĸ 2026-06-18T13:30:00Z
The Medicare Crisis for Insurers Is Over. The Easy Gains Are Too.
The Wall Street Journal âĸ 2026-06-17T09:30:00Z
Why Did UnitedHealth Stock Choose Pain Over Growth?
Trefis âĸ 2026-06-16T15:44:47Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $129,664,000,000 | $117,761,000,000 | $106,374,000,000 | $92,870,000,000 |
| Operating Revenue | $129,664,000,000 | $117,761,000,000 | $106,374,000,000 | $92,870,000,000 |
| Expenses | ||||
| Interest Expense | $631,000,000 | $660,000,000 | $493,000,000 | $401,000,000 |
| Total Expenses | $128,109,000,000 | $116,040,000,000 | $102,991,000,000 | $89,302,000,000 |
| Net Non Operating Interest Income Expense | $-631,000,000 | $-660,000,000 | $-493,000,000 | $-401,000,000 |
| Interest Expense Non Operating | $631,000,000 | $660,000,000 | $493,000,000 | $401,000,000 |
| Other Operating Expenses | $15,901,000,000 | $13,877,000,000 | $13,325,000,000 | $12,739,000,000 |
| Loss Adjustment Expense | $110,812,000,000 | $100,664,000,000 | $88,394,000,000 | $75,690,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,188,000,000 | $1,207,000,000 | $2,489,000,000 | $2,806,000,000 |
| Net Interest Income | $-631,000,000 | $-660,000,000 | $-493,000,000 | $-401,000,000 |
| Normalized Income | $1,243,342,000 | $1,207,000,000 | $2,489,000,000 | $2,619,614,910 |
| Net Income From Continuing And Discontinued Operation | $1,188,000,000 | $1,207,000,000 | $2,489,000,000 | $2,806,000,000 |
| Net Income Common Stockholders | $1,188,000,000 | $1,207,000,000 | $2,489,000,000 | $2,806,000,000 |
| Net Income | $1,188,000,000 | $1,207,000,000 | $2,489,000,000 | $2,806,000,000 |
| Net Income Including Noncontrolling Interests | $1,203,000,000 | $1,214,000,000 | $2,484,000,000 | $2,802,000,000 |
| Net Income Continuous Operations | $1,203,000,000 | $1,214,000,000 | $2,484,000,000 | $2,802,000,000 |
| Earnings From Equity Interest Net Of Tax | $-102,000,000 | $-94,000,000 | $-63,000,000 | $-4,000,000 |
| Pretax Income | $1,555,000,000 | $1,721,000,000 | $3,383,000,000 | $3,568,000,000 |
| Special Income Charges | $-67,000,000 | $0 | $0 | $237,000,000 |
| Depreciation And Amortization In Income Statement | $698,000,000 | $839,000,000 | $779,000,000 | $709,000,000 |
| Per Share | ||||
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 |
| Basic EPS | $9.87 | $10.01 | $20.09 | $22.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $-11,658,000 | $0 | $0 | $50,614,910 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Total Unusual Items | $-67,000,000 | $0 | $0 | $237,000,000 |
| Total Unusual Items Excluding Goodwill | $-67,000,000 | $0 | $0 | $237,000,000 |
| Reconciled Depreciation | $824,000,000 | $968,000,000 | $917,000,000 | $845,000,000 |
| EBIT | $2,186,000,000 | $2,381,000,000 | $3,876,000,000 | $3,969,000,000 |
| Diluted Average Shares | $120,826,000 | $120,869,000 | $124,441,000 | $127,094,000 |
| Basic Average Shares | $120,454,000 | $120,571,000 | $123,866,000 | $126,419,000 |
| Diluted NI Availto Com Stockholders | $1,188,000,000 | $1,207,000,000 | $2,489,000,000 | $2,806,000,000 |
| Minority Interests | $-15,000,000 | $-7,000,000 | $5,000,000 | $4,000,000 |
| Tax Provision | $250,000,000 | $413,000,000 | $836,000,000 | $762,000,000 |
| Other Special Charges | $67,000,000 | - | - | $-237,000,000 |
| Net Policyholder Benefits And Claims | $110,812,000,000 | $100,664,000,000 | $88,394,000,000 | $75,690,000,000 |
Fetched: 2026-06-08
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,843,000,000 | $5,302,000,000 | $5,019,000,000 | $4,404,000,000 |
| Total Assets | $48,909,000,000 | $46,479,000,000 | $47,065,000,000 | $43,055,000,000 |
| Goodwill And Other Intangible Assets | $10,814,000,000 | $11,073,000,000 | $11,243,000,000 | $10,907,000,000 |
| Other Intangible Assets | $1,128,000,000 | $1,442,000,000 | $1,693,000,000 | $1,765,000,000 |
| Receivables | $3,270,000,000 | $2,704,000,000 | $2,035,000,000 | $1,674,000,000 |
| Accounts Receivable | $3,270,000,000 | $2,704,000,000 | $2,035,000,000 | $1,674,000,000 |
| Cash Cash Equivalents And Short Term Investments | $19,903,000,000 | $20,435,000,000 | $21,320,000,000 | $18,942,000,000 |
| Cash And Cash Equivalents | $4,200,000,000 | $2,221,000,000 | $4,694,000,000 | $5,061,000,000 |
| Debt | ||||
| Net Debt | $8,169,000,000 | $9,500,000,000 | $6,962,000,000 | $6,065,000,000 |
| Total Debt | $12,369,000,000 | $11,721,000,000 | $11,656,000,000 | $11,126,000,000 |
| Long Term Debt And Capital Lease Obligation | $12,369,000,000 | $11,144,000,000 | $10,213,000,000 | $7,935,000,000 |
| Long Term Debt | $12,369,000,000 | $11,144,000,000 | $10,213,000,000 | $7,935,000,000 |
| Current Debt And Capital Lease Obligation | $0 | $577,000,000 | $1,443,000,000 | $3,191,000,000 |
| Current Debt | $0 | $577,000,000 | $1,443,000,000 | $3,191,000,000 |
| Other Current Borrowings | - | - | $0 | $500,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $31,172,000,000 | $30,034,000,000 | $30,747,000,000 | $27,685,000,000 |
| Non Current Deferred Liabilities | $356,000,000 | $260,000,000 | $266,000,000 | $286,000,000 |
| Current Notes Payable | $0 | $577,000,000 | $572,000,000 | $2,096,000,000 |
| Payables And Accrued Expenses | $15,990,000,000 | $16,102,000,000 | $17,163,000,000 | $14,800,000,000 |
| Payables | $15,990,000,000 | $16,102,000,000 | $17,163,000,000 | $14,800,000,000 |
| Other Payable | $306,000,000 | $403,000,000 | $353,000,000 | $298,000,000 |
| Accounts Payable | $15,684,000,000 | $15,699,000,000 | $16,810,000,000 | $14,502,000,000 |
| Equity | ||||
| Common Stock Equity | $17,657,000,000 | $16,375,000,000 | $16,262,000,000 | $15,311,000,000 |
| Total Equity Gross Minority Interest | $17,737,000,000 | $16,445,000,000 | $16,318,000,000 | $15,370,000,000 |
| Stockholders Equity | $17,657,000,000 | $16,375,000,000 | $16,262,000,000 | $15,311,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-633,000,000 | $-1,067,000,000 | $-999,000,000 | $-1,304,000,000 |
| Other Equity Adjustments | $-633,000,000 | $-1,067,000,000 | $-999,000,000 | $-1,304,000,000 |
| Retained Earnings | $29,075,000,000 | $28,317,000,000 | $27,540,000,000 | $25,492,000,000 |
| Long Term Equity Investment | $638,000,000 | $697,000,000 | $740,000,000 | $749,000,000 |
| Investments In Other Ventures Under Equity Method | $638,000,000 | $697,000,000 | $740,000,000 | $749,000,000 |
| Other | ||||
| Treasury Shares Number | $78,128,009 | $78,077,195 | $76,465,862 | $73,691,955 |
| Ordinary Shares Number | $120,591,312 | $120,641,615 | $122,224,220 | $124,974,643 |
| Share Issued | $198,719,321 | $198,718,810 | $198,690,082 | $198,666,598 |
| Tangible Book Value | $6,843,000,000 | $5,302,000,000 | $5,019,000,000 | $4,404,000,000 |
| Invested Capital | $30,026,000,000 | $28,096,000,000 | $27,918,000,000 | $26,437,000,000 |
| Total Capitalization | $30,026,000,000 | $27,519,000,000 | $26,475,000,000 | $23,246,000,000 |
| Minority Interest | $80,000,000 | $70,000,000 | $56,000,000 | $59,000,000 |
| Treasury Stock | $14,418,000,000 | $14,371,000,000 | $13,658,000,000 | $12,156,000,000 |
| Additional Paid In Capital | $3,600,000,000 | $3,463,000,000 | $3,346,000,000 | $3,246,000,000 |
| Capital Stock | $33,000,000 | $33,000,000 | $33,000,000 | $33,000,000 |
| Common Stock | $33,000,000 | $33,000,000 | $33,000,000 | $33,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $356,000,000 | $260,000,000 | $266,000,000 | $286,000,000 |
| Investments And Advances | $16,834,000,000 | $19,332,000,000 | $17,748,000,000 | $15,010,000,000 |
| Goodwill | $9,686,000,000 | $9,631,000,000 | $9,550,000,000 | $9,142,000,000 |
| Net PPE | $2,231,000,000 | $2,532,000,000 | $3,030,000,000 | $3,221,000,000 |
| Other Short Term Investments | $15,703,000,000 | $18,214,000,000 | $16,626,000,000 | $13,881,000,000 |
| Commercial Paper | - | $0 | $871,000,000 | $595,000,000 |
Fetched: 2026-06-08
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $375,000,000 | $2,391,000,000 | $2,977,000,000 | $3,450,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $921,000,000 | $2,966,000,000 | $3,981,000,000 | $4,587,000,000 |
| Cash Flow From Continuing Operating Activities | $921,000,000 | $2,966,000,000 | $3,981,000,000 | $4,587,000,000 |
| Operating Gains Losses | $219,000,000 | $70,000,000 | $117,000,000 | $-28,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-546,000,000 | $-575,000,000 | $-1,004,000,000 | $-1,137,000,000 |
| Investing Cash Flow | $2,273,000,000 | $-2,952,000,000 | $-3,492,000,000 | $-1,006,000,000 |
| Cash Flow From Continuing Investing Activities | $2,273,000,000 | $-2,952,000,000 | $-3,492,000,000 | $-1,006,000,000 |
| Net Other Investing Changes | $-220,000,000 | $-468,000,000 | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-151,000,000 | $-817,000,000 | $-1,573,000,000 | $-2,096,000,000 |
| Financing Cash Flow | $-1,215,000,000 | $-2,487,000,000 | $-856,000,000 | $-1,914,000,000 |
| Cash Flow From Continuing Financing Activities | $-1,215,000,000 | $-2,487,000,000 | $-856,000,000 | $-1,914,000,000 |
| Net Other Financing Charges | $-1,285,000,000 | $-1,925,000,000 | $670,000,000 | $1,968,000,000 |
| Cash Dividends Paid | $-430,000,000 | $-431,000,000 | $-431,000,000 | $-392,000,000 |
| Common Stock Dividend Paid | $-430,000,000 | $-431,000,000 | $-431,000,000 | $-392,000,000 |
| Net Common Stock Issuance | $-151,000,000 | $-817,000,000 | $-1,573,000,000 | $-2,096,000,000 |
| Other | ||||
| Repayment Of Debt | $-1,050,000,000 | $-2,014,000,000 | $-2,432,000,000 | $-3,376,000,000 |
| Issuance Of Debt | $1,481,000,000 | $2,282,000,000 | $2,910,000,000 | $1,982,000,000 |
| Interest Paid Supplemental Data | $628,000,000 | $584,000,000 | $394,000,000 | $354,000,000 |
| Income Tax Paid Supplemental Data | $231,000,000 | $506,000,000 | $903,000,000 | $758,000,000 |
| End Cash Position | $4,200,000,000 | $2,221,000,000 | $4,694,000,000 | $5,061,000,000 |
| Beginning Cash Position | $2,221,000,000 | $4,694,000,000 | $5,061,000,000 | $3,394,000,000 |
| Changes In Cash | $1,979,000,000 | $-2,473,000,000 | $-367,000,000 | $1,667,000,000 |
| Common Stock Payments | $-151,000,000 | $-817,000,000 | $-1,573,000,000 | $-2,096,000,000 |
| Net Issuance Payments Of Debt | $431,000,000 | $268,000,000 | $478,000,000 | $-1,394,000,000 |
| Net Short Term Debt Issuance | $-102,000,000 | $-857,000,000 | $266,000,000 | $-376,000,000 |
| Short Term Debt Payments | $-102,000,000 | $-907,000,000 | $-100,000,000 | $-376,000,000 |
| Short Term Debt Issuance | $0 | $50,000,000 | $366,000,000 | $0 |
| Net Long Term Debt Issuance | $533,000,000 | $1,125,000,000 | $212,000,000 | $-1,018,000,000 |
| Long Term Debt Payments | $-948,000,000 | $-1,107,000,000 | $-2,332,000,000 | $-3,000,000,000 |
| Long Term Debt Issuance | $1,481,000,000 | $2,232,000,000 | $2,544,000,000 | $1,982,000,000 |
| Net Investment Purchase And Sale | $2,982,000,000 | $-1,827,000,000 | $-2,465,000,000 | $-2,250,000,000 |
| Sale Of Investment | $9,422,000,000 | $6,358,000,000 | $5,087,000,000 | $3,799,000,000 |
| Purchase Of Investment | $-6,440,000,000 | $-8,185,000,000 | $-7,552,000,000 | $-6,049,000,000 |
| Net Business Purchase And Sale | $34,000,000 | $-89,000,000 | $-233,000,000 | $2,364,000,000 |
| Sale Of Business | $115,000,000 | $0 | $0 | $2,701,000,000 |
| Purchase Of Business | $-81,000,000 | $-89,000,000 | $-233,000,000 | $-337,000,000 |
| Net PPE Purchase And Sale | $-523,000,000 | $-568,000,000 | $-794,000,000 | $-1,120,000,000 |
| Sale Of PPE | $23,000,000 | $7,000,000 | $210,000,000 | $17,000,000 |
| Purchase Of PPE | $-546,000,000 | $-575,000,000 | $-1,004,000,000 | $-1,137,000,000 |
| Change In Working Capital | $-1,797,000,000 | $154,000,000 | $81,000,000 | $534,000,000 |
| Change In Other Working Capital | $96,000,000 | $-6,000,000 | $-20,000,000 | $32,000,000 |
| Change In Other Current Liabilities | $1,322,000,000 | $-373,000,000 | $841,000,000 | $44,000,000 |
| Change In Other Current Assets | $-2,173,000,000 | $1,003,000,000 | $-1,318,000,000 | $-463,000,000 |
| Change In Payables And Accrued Expense | $-472,000,000 | $199,000,000 | $915,000,000 | $975,000,000 |
| Change In Payable | $-472,000,000 | $199,000,000 | $915,000,000 | $975,000,000 |
| Change In Account Payable | $-472,000,000 | $199,000,000 | $915,000,000 | $975,000,000 |
| Change In Receivables | $-570,000,000 | $-669,000,000 | $-337,000,000 | $-54,000,000 |
| Stock Based Compensation | $241,000,000 | $207,000,000 | $175,000,000 | $216,000,000 |
| Asset Impairment Charge | $156,000,000 | $437,000,000 | $261,000,000 | $248,000,000 |
| Deferred Tax | $75,000,000 | $-192,000,000 | $-167,000,000 | $-100,000,000 |
| Deferred Income Tax | $75,000,000 | $-192,000,000 | $-167,000,000 | $-100,000,000 |
| Depreciation And Amortization | $824,000,000 | $968,000,000 | $917,000,000 | $845,000,000 |
| Amortization Cash Flow | $51,000,000 | $60,000,000 | $67,000,000 | $96,000,000 |
| Amortization Of Intangibles | $51,000,000 | $60,000,000 | $67,000,000 | $96,000,000 |
| Depreciation | $773,000,000 | $908,000,000 | $850,000,000 | $749,000,000 |
| Earnings Losses From Equity Investments | $102,000,000 | $94,000,000 | $63,000,000 | $4,000,000 |
| Gain Loss On Investment Securities | $50,000,000 | $-24,000,000 | $54,000,000 | $205,000,000 |
| Gain Loss On Sale Of Business | $67,000,000 | $0 | $0 | $-237,000,000 |
| Net Income From Continuing Operations | $1,203,000,000 | $1,214,000,000 | $2,484,000,000 | $2,802,000,000 |
| Other Non Cash Items | - | $108,000,000 | $113,000,000 | $70,000,000 |
| Proceeds From Stock Option Exercised | - | - | - | - |
Fetched: 2026-06-08